Back
Foghorn Therapeutics, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
35
FHTX
Foghorn Therapeutics, Inc.
Last Price:
$4.37
Seasonality Move:
-23.21%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiFoghorn Therapeutics, Inc. Stock Forecast
-
Is Foghorn Therapeutics, Inc. Stock Undervalued?The current Foghorn Therapeutics, Inc. [FHTX] share price is $4.58. The Score for FHTX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
FHTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Foghorn Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Foghorn Therapeutics, Inc. Stock Rating
Data Unavailable
Foghorn Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
foghorntx.com
52-Week Data
52-Week High:
7.42
52-Week Low:
2.94
Prediction Charts
Market Cap:
259M
Price in USD:
4.58
Volume:
164.8K
Beta:
3.02
Technical Analysis
SMA50:
4.43
SMA100:
4.89
SMA200:
4.64
52-Wk Change:
-37.94%
Stock Predictions
-
Is Foghorn Therapeutics, Inc. stock public?Yes, Foghorn Therapeutics, Inc. is a publicly traded company.
-
What is the Foghorn Therapeutics, Inc. stock quote today?The Foghorn Therapeutics, Inc. stock price is 4.58 USD today.
-
How to buy Foghorn Therapeutics, Inc. stock online?You can buy Foghorn Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 4.35 | 4.69 | 4.75 | 4.22 |
| Nov-17 | 4.90 | 4.81 | 5.69 | 4.75 |
| Nov-18 | 4.72 | 5.02 | 5.02 | 4.63 |
| Nov-19 | 5.04 | 4.86 | 5.26 | 4.83 |
| Nov-20 | 5.01 | 4.59 | 5.11 | 4.56 |
| Nov-21 | 4.59 | 4.62 | 4.89 | 4.54 |
| Nov-24 | 4.61 | 4.56 | 4.81 | 4.51 |
| Nov-25 | 4.60 | 4.72 | 4.76 | 4.40 |
| Nov-26 | 4.70 | 4.81 | 4.86 | 4.65 |
| Nov-28 | 4.81 | 4.75 | 4.87 | 4.65 |
| Dec-1 | 4.73 | 4.40 | 4.73 | 4.36 |
| Dec-2 | 4.43 | 4.29 | 4.52 | 4.29 |
| Dec-3 | 4.32 | 4.44 | 4.47 | 4.27 |
| Dec-4 | 4.56 | 4.58 | 4.81 | 4.50 |
Foghorn Therapeutics, Inc. Earnings
Data Unavailable
Foghorn Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.08 per share.
* Foghorn Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.